SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Ambit Biosciences and Teva Pharmaceutical Industries Limited Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor